EpiVax Therapeutics jobs and careers
Providence, RI, United States
About EpiVax Therapeutics
EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.
Founded in 2017 by Anne S. De Groot, Bill Martin and Gad Berdugo.
- Founded
- 2017
- Employees
- 1 to 10
- Total funding
- $1.5M
- Headquarters
- Providence
Leadership
The top of EpiVax Therapeutics's org chart, with how many people report into each leader.
AG
Annie De Groot
CEO
3 reports
GC
Gregory Covino
CFO
GS
Gary Steinberg
Chief Medical Officer
WM
William Martin
Co-Founder, COO & CIO
Board
MC
Manon Cox
Advisor
JL
Judy Lieberman
Advisor
DB
Dominique Bridon
Advisor
RL
Richard Lipkin
Director
DA
Dan Adams
Chairman, Board of Directors
AR
Amy Rosenberg
Advisor
Jobs at EpiVax Therapeutics
No open positions right now. Explore more companies on TheJobsMap.